Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1178
https://www.valueinhealthjournal.com/article/S1098-3015(15)01235-8/fulltext
Title :
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01235-8&doi=10.1016/j.jval.2015.03.1178
First page :
A203
Section Title :
Cancer
Open access? :
No
Section Order :
640